Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Anterogen Co., Ltd. clinical trials
The registry lists 31 studies whose lead sponsor is Anterogen Co., Ltd.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 29, 2025.
Keep track of what changes. Save the Anterogen Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Anterogen Co., Ltd..
- Anterogen Co., Ltd.31 studiesSame company
Something wrong?
Focus areas
Conditions Anterogen Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 31 of 31.
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical TrialRecruitingNCT06141811
- Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis BullosaRecruitingNCT05157958Phase 2
- A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's DiseaseRecruitingNCT02580617Phase 1
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical TrialRecruitingNCT03183661
- Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot UlcersRecruitingNCT04497805Phase 2
- Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's FistulaActive, not recruitingNCT04612465Phase 3
- Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/LActive, not recruitingNCT06539429Phase 1
- Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.CompletedNCT04569409Phase 3
- Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot UlcersCompletedNCT03754465Phase 2
- Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.CompletedNCT03370874Phase 3
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical TrialCompletedNCT03183648
- Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis BullosaCompletedNCT02579369Phase 1/2
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical TrialCompletedNCT03183804
- A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical TrialCompletedNCT03183934
- Study of Allogenic Adipose-derived Stem Cells in Crohn's FistulaCompletedNCT01440699Phase 1
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical TrialCompletedNCT04590703
- A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury SubjectsCompletedNCT02619851Phase 2
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical TrialCompletedNCT03183726
- A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical TrialCompletedNCT03183622
- Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot UlcersCompletedNCT02619877Phase 2
- Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex FistulaTerminatedNCT01314092Phase 2
- Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's FistulaCompletedNCT01314079
- Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211)TerminatedNCT01623453
- Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral EpicondylitisCompletedNCT02131077Phase 1/2
- A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn WoundCompletedNCT02394873Phase 1
- Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot UlcersCompletedNCT02394886Phase 1
- Safety of Repaircell in Healthy VolunteersCompletedNCT01739530Phase 1
- Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's FistulaCompletedNCT01011244Phase 2
- Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal IncontinenceTerminatedNCT01011686Phase 1
- Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's FistulaCompletedNCT00992485Phase 1
- Safety and Efficacy of Autologous Cultured Adipocytes in Patient With Depressed ScarCompletedNCT00992147Phase 2/3